Navigation Links
Monash wins $32m for health and medical research
Date:10/17/2008

Monash University has secured $32 million in the latest round of National Health and Medical Research Council (NHMRC) funding the University's highest ever NHMRC funding amount for the greatest number of projects.

Federal Health Minister Nicola Roxon announced the health and medical research grants today.

Monash University researchers will share in a total of $32M for 62 individual projects, including:

  • $1.8 million for research into the effect of Erythropoietin (EPO) on traumatic brain injury;
  • $491,250 to research testicular development and disease;
  • $312,500 to explore novel treatment strategies for cardiovascular disease;
  • $556,500 allocated for research into the impact of low oxygen supplies to the fetal brain; and
  • $900,825 for continuing medical education and feedback to alert diabetes population outcomes.

Another successful application was for $673,000 to follow up an initial investigation of estrogen as an effective treatment for schizophrenia, allowing a clinical trial in 180 postmenopausal women with schizophrenia using a selective estrogen receptor modulator.

A team of researchers from the Department of Epidemiology and Preventive Medicine also secured $531,000 to investigate whether mobile phones affect cognitive development in children. A further $682,875 was awarded to a team from the School of Psychology, Psychiatry and Psychological Medicine to investigate the effect of light intervention on shift workers.

Deputy Vice-Chancellor (Research) Professor Edwina Cornish said the Federal Government's generous allocation was confirmation that Monash researchers excelled in the delivery of quality research outcomes.

"Our scientific and medical research teams are among the best in the world and it is encouraging for them to know their endeavours have the full support of the Federal Government and NHMRC," Professor Cornish
'/>"/>

Contact: Samantha Blair
samantha.blair@adm.monash.edu.au
61-399-034-841
Monash University
Source:Eurekalert

0

GOOD

Page: 1 2

Related medicine news :

1. Turner Universal Awarded Contracts Totaling $227 Million to Manage Construction of Two Tennessee Healthcare Facilities
2. Huston Street Joins Mended Hearts with an Important Heart Health Message: Get Your Flu Shot!
3. AMN Healthcare Services to Present at the BIOCOM Investor Conference
4. New National Public Opinion Survey Reveals Important Findings on Oral Health Care Perceptions
5. XIRING and SCM Microsystems Jointly Develop Mobile Terminals for German eHealth Market
6. MyHealthGate, Inc. Joins With LiveActive Chewy Granola Bars to Raise Digestive Health Awareness
7. New EPA Lead Standard Significantly Improved to Protect Kids Health
8. Albany College of Pharmacy and Health Sciences - New Name, Same Commitment to the Advancement of Health Care
9. Prevention is the Key to Solving Health Care Crisis;
10. Important Health Issue From Be Oyster Aware
11. With the Economy of the United States at a Turning Point, Health Care Could Be Our Next Serious Crisis ...
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... these findings in the current online edition of ... study could open up new possibilities of early ... tackle diseases before the patient,s nervous system is ... of genetic diseases of the cerebellum and other ... limited control of their muscles. They also suffer ...
(Date:5/22/2013)... baby to finish the last ounce in their bottle might ... soon burn off, a bad habit remains. , Brigham Young ... clinical obesity at 24 months of age strongly traces back ... two, it puts you on a trajectory where you are ... as an adult," said Forste. "That,s a big concern." , ...
(Date:5/22/2013)... May 22, 2013 College and ... access to Adapt Courseware’s new Introduction to ... adaptive framework that responds based on each student’s ... the provider of comprehensive adaptive online curriculum resources ... to develop introductory level general education offerings, enabling ...
(Date:5/22/2013)... 22, 2013 Officials with Alliance Commercial ... cicada services are now in full effect due to ... cicada cycle emerges. , “The cicada emerges in ... they will emerge, so we’re now offering services to ... protected during the invasion,” said R. Brett Madden, Esq., ...
(Date:5/22/2013)... (PRWEB) May 22, 2013 According to ... an autoimmune disorder effecting up to 3 million people ... damage to the small intestine and mal-absorption of nutrients(2). ... as diarrhea, constipation, weight loss and vitamin deficiency, people ... While there are many gluten-free foods that celiac sufferers ...
Breaking Medicine News(10 mins):Health News:A pan-European study: Signs of motor disorders can appear years before disease manifestation 2Health News:A pan-European study: Signs of motor disorders can appear years before disease manifestation 3Health News:Overeating learned in infancy, study suggests 2Health News:Adapt Courseware Releases Introduction to Sociology for Colleges and Universities Nationwide 2Health News:Adapt Courseware Releases Introduction to Sociology for Colleges and Universities Nationwide 3Health News:Alliance Commercial Pest Control, Inc. Now Offering Cicada Protection Services 2Health News:During Celiac Awareness Month, Nutrition Expert Keri Glassman Encourages People with Celiac Disease to Find a Fiber Alternative like Konsyl Original Formula 2Health News:During Celiac Awareness Month, Nutrition Expert Keri Glassman Encourages People with Celiac Disease to Find a Fiber Alternative like Konsyl Original Formula 3
... troubles ,the day after, and protect liver from damage, experts ... a hangover, drink lots of water, get plenty of rest ... study shows that the amino acids and minerals in asparagus ... toxins in alcohol. , Researchers at the Institute of Medical ...
... a technique widely used in studying the human brain. ... signals are generated at brain cell level. This information ... from the Academy of Finland,s Neuroscience Research Programme (NEURO) ... play a key role in the generation of fMRI ...
... and the University of Pittsburgh Medical Center will be ... conjunction with the G20 Pittsburgh Summit Sept. 24-25. These ... how and why the "eds and meds" sector of ... region,s success. The Eds-Meds program will begin at ...
... , RUTHERFORD, N.J., Aug. 28 As ... to soar, and sales and profits are being diverted ... commitment to keep their Vectra(R) products, and the health ... professionals. Through their Bloodhound(R) Technology, a unique track-and-trace barcode ...
... MUMBAI, India, Aug. 28 Sun Pharmaceutical Industries Ltd. (Reuters: ... announced that on August 27, 2009, Sun filed a new ... Antitrust Division of the U.S. Department of Justice to restart ... Tender Offer by Alkaloida Chemical Company Exclusive Group Ltd. (Alkaloida), ...
... someday aid in understanding ADD and more , FRIDAY, Aug. ... in a crowd, it appears that your "mind,s eye" acts ... you until you find the right person. , Researchers from ... monkeys as they searched for a specific tilted, colored bar ...
Cached Medicine News:Health News:Asparagus May Ease Hangover 2Health News:New research findings pave the way to more accurate interpretation of brain imaging data 2Health News:Summit VetPharm Helps Veterinarians Protect Against Product Diversion, Counterfeiting and Shrinkage Using Vectra(R) Bloodhound(R) Technology 2Health News:Summit VetPharm Helps Veterinarians Protect Against Product Diversion, Counterfeiting and Shrinkage Using Vectra(R) Bloodhound(R) Technology 3Health News:Sun Pharmaceutical Files HSR Application for Taro Tender Offer 2Health News:Sun Pharmaceutical Files HSR Application for Taro Tender Offer 3Health News:Brain May Use Its 'Mind's Eye' to Control Chaos 2
(Date:5/22/2013)... Mass. and TORONTO , ... ) (OTCBB: GNBT) today announced three presentations demonstrating the ... by its wholly-owned subsidiary, Antigen Express, Inc. ( www.antigenexpress.com ... meeting of the American Society of Clinical Oncology (ASCO) ... from May 31 through June 4, 2013. ...
(Date:5/22/2013)...  Grifols, ein globales Unternehmen der Gesundheitsbranche ... , Spanien, präsentierte die Ergebnisse einer Studie, ... PROLASTIN©-C (Alpha1-Proteinasehemmer [human]) den Spiegel des Alpha1-Proteins ... Niveau anhebt, das innerhalb des für gesunde ... eine lebensbedrohliche, genetische Erkrankung, bei der der ...
(Date:5/22/2013)... and TORONTO , May 22, 2013 ... that John Mon , Chief Operating Officer, ... on Thursday, May 30, 2013 in New York ... The Company,s presentation is scheduled to begin at 4:00 ... To access the webcast, go to:   http://wsw.com/webcast/marcum/mfs.v/   ...
Breaking Medicine Technology:Generex Announces ASCO Presentations on the Antigen Express Advanced Stage AE37 Cancer Vaccine 2Generex Announces ASCO Presentations on the Antigen Express Advanced Stage AE37 Cancer Vaccine 3Generex Announces ASCO Presentations on the Antigen Express Advanced Stage AE37 Cancer Vaccine 4Studie von Grifols zeigt, dass eine höhere Dosis von PROLASTIN-C den Alpha1-PI-Spiegel in Patienten mit AAT-Mangel in den normalen Bereich anhebt 2Studie von Grifols zeigt, dass eine höhere Dosis von PROLASTIN-C den Alpha1-PI-Spiegel in Patienten mit AAT-Mangel in den normalen Bereich anhebt 3Studie von Grifols zeigt, dass eine höhere Dosis von PROLASTIN-C den Alpha1-PI-Spiegel in Patienten mit AAT-Mangel in den normalen Bereich anhebt 4Medifocus, Inc. to Present At The Second Annual Marcum LLP MicroCap Conference 2Medifocus, Inc. to Present At The Second Annual Marcum LLP MicroCap Conference 3
... Trubion,s Proprietary ... Product Candidate, SBI-087 for RA Expands Trubion,s Family of Customized, Differentiated ... Product Candidates, ... has initiated a Phase 1/2,clinical trial of TRU-016, the company,s lead proprietary Small Modular,ImmunoPharmaceutical ...
... Encouraging Response in CF Patients - Results Validate ... March 27 The Cystic Fibrosis Foundation,announced today that ... defect in CF, showed promising results in an ongoing ... mutation of CF. The drug is,being developed by Vertex ...
Cached Medicine Technology:Trubion Initiates Phase 1/2 Study of TRU-016 in CLL, Announces Next-Generation Product Candidate for RA and Provides Product Pipeline Update 2Trubion Initiates Phase 1/2 Study of TRU-016 in CLL, Announces Next-Generation Product Candidate for RA and Provides Product Pipeline Update 3Trubion Initiates Phase 1/2 Study of TRU-016 in CLL, Announces Next-Generation Product Candidate for RA and Provides Product Pipeline Update 4Trubion Initiates Phase 1/2 Study of TRU-016 in CLL, Announces Next-Generation Product Candidate for RA and Provides Product Pipeline Update 5Cystic Fibrosis Foundation Announces Positive Early Results for Phase 2 Clinical Trial of VX-770 - an Oral Compound to Treat CF 2Cystic Fibrosis Foundation Announces Positive Early Results for Phase 2 Clinical Trial of VX-770 - an Oral Compound to Treat CF 3
Malaria Pf. Assay Range...
An immunochromatographic test for detection of 4 species of Plasmodium antigen ( P. falciparum , P. vivax , P. malariae , P. ovale ) in whole blood....
192 Test HRP-II Enzyme Immunoassay for the presence of Plasmodium falciparum infection....
Malaria device / strip (3 line, PAN-pLDH, P.f.-HRP2)...
Medicine Products: